advertisement
Experimental Glaucoma: Pathophysiology of RGC loss (14-3, April 2013) on:
51056 Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens
Joachim SC; Gramlich OW; Laspas P et al.
PLoS ONE 2012; 7: e40616
Basic research: Immunoregulation (10-1, July 2008) on:
20826 Prevalence of serum autoantibodies and paraproteins in patients with glaucoma
Hammam T; Montgomery D; Morris D et al.
Eye 2008; 22: 349-353
Clinical Glaucoma: PPA after AACG (9-3, December 2007) on:
19519 Peripapillary atrophy after acute primary angle closure
Lee KY; Rensch F; Aung T et al.
British Journal of Ophthalmology 2007; 91: 1059-1061
Medical treatment: Citicolin (8-4, March 2007) on:
15272 Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat
Schuettauf F; Rejdak R; Thaler S et al.
Experimental Eye Research 2006; 83: 1128-1134
Basic research: Thymulin (8-3, December 2006) on:
14030 Plasma thymulin and nerve growth factor levels in patients with primary open angle glaucoma and elevated intraocular pressure
Noureddin BN; Al-Haddad CE; Bashshur Z et al.
Graefe's Archive for Clinical and Experimental Ophthalmology 2006; 244: 750-752
Basic research: Endothelin and astrocytes (8-2, September 2006) on:
13731 Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage
Wang L; Fortune B; Cull G et al.
Archives of Ophthalmology 2006; 124: 717-724
Basic science: NGF as neuroprotectant (7-3, March 2006) on:
13176 Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats
Lambiase A; Tirassa P; Micera A et al.
Investigative Ophthalmology and Visual Science 2005; 46: 3800-3806
Basic research: Regulation of outflow (7-1, June 2005) on:
11728 Plasminogen activator inhibitor-1 in the aqueous humor of patients with and without glaucoma
Dan J; Belyea D; Gertner G et al.
Archives of Ophthalmology 2005; 123: 220-224